1. What Is the Point of Care Infectious Disease Testing Market?
The Point of Care Infectious Disease Testing Market covers rapid and near-patient molecular and immunoassay-based tests for sexually transmitted infections, tropical diseases, hepatitis, HIV, and other communicable diseases outside of centralized laboratory infrastructure. Public health clinicians, primary care physicians, and community health workers deploy POC STI tests, HIV rapid tests, malaria and dengue antigen tests, and TB molecular tests in clinics, community settings, and field programs where laboratory access is limited. The market includes STI POC panels, HIV POC tests, tropical disease diagnostics, and TB molecular POC.
2. Point of Care Infectious Disease Testing Market Size & Forecast
3. Emerging Technologies
- CRISPR-based POC infectious disease detection providing high-sensitivity nucleic acid identification without thermocycling for simplified field deployment.
- Multiplexed STI panels detecting chlamydia, gonorrhea, syphilis, and trichomonas from a single swab sample in a single POC test.
- Smartphone-integrated antigen test readers providing quantitative result interpretation for borderline positive samples improving POC diagnostic accuracy.
- Ultra-low-cost paper microfluidic tests enabling sub-dollar cost POC diagnostics for global health applications.
Similar technologies are also transforming adjacent markets. Learn more in our Rapid Antigen Tests Market.
4. Key Market Opportunity
STI POC program expansion in sexual health clinics and community settings represents the largest public health investment driver. Malaria RDT public health procurement is the largest global volume opportunity. HIV self-testing distribution program expansion is the fastest-growing HIV testing market segment.
5. Top Companies in the Point of Care Infectious Disease Testing Market
The following organisations hold leading positions in the Point of Care Infectious Disease Testing Market. The full report provides revenue share, SWOT analysis, and competitive benchmarking for each player.
- Abbott Laboratories
- Roche Diagnostics
- bioMerieux
- Cepheid
- SD Biosensor
- Chembio Diagnostics
- OraSure Technologies
- Molbio Diagnostics
- Tulip Diagnostics
- Atomo Diagnostics
6. Market Segmentation
The Point of Care Infectious Disease Testing Market is analysed across 4 segmentation dimensions. Revenue data, growth rates, and competitive intensity by sub-segment are available in the full report.
| Segmentation | Sub-Segments |
|---|---|
| By Disease Category | HIV POC TestingSTI POC Testing including Chlamydia and GonorrheaMalaria and Dengue POCHepatitis B and C POCTuberculosis Molecular POC |
| By Technology | Lateral Flow Rapid TestsMicrofluidic Molecular POCImmunochromatographic AssaysLAMP Amplification |
| By Setting | Primary Care and Community ClinicsPublic Health Field ProgramsLow-Resource SettingsEmergency DepartmentsSexual Health Clinics |
| By Geography | North AmericaEuropeAsia PacificLatin AmericaMiddle East and Africa |
7. Key Market Trends (2026–2034)
Three major forces are shaping the Point of Care Infectious Disease Testing Market trajectory over the forecast period:
STI POC testing expansion is addressing a public health priority as chlamydia, gonorrhea, and syphilis incidence continues rising in developed and developing country settings.Traditional STI testing requiring laboratory central processing with delayed results creates loss-to-follow-up reducing treatment rates. POC STI tests enabling same-visit diagnosis and treatment are demonstrating improved treatment rates in sexual health clinic settings. Cepheid GeneXpert CT/NG and similar POC molecular STI tests are gaining systematic adoption.
HIV self-testing is expanding HIV diagnosis beyond clinical settings by enabling individuals to test themselves at home or in community settings.WHO-prequalified HIV self-test kits deployed through pharmacy, community distribution, and mail-order programs are systematically expanding HIV testing coverage in high-burden settings. The self-testing expansion is creating new distribution channels for HIV POC products beyond clinic-based testing.
Malaria and dengue POC testing remains a critical global health priority as endemic tropical disease diagnosis in resource-limited settings requires simple accurate tests deployable without laboratory infrastructure.WHO-prequalified malaria rapid diagnostic tests and dengue antigen-antibody combination tests serve substantial public health procurement from UNICEF, PEPFAR, and national malaria programs. The public health procurement creates high-volume demand for affordable POC tropical disease diagnostics.
For related market intelligence, see the Point Of Care Testing Market.
8. Segmental Analysis
By disease category, the malaria and dengue POC segment dominated the Point of Care Infectious Disease Testing Market in 2025, as high-volume public health malaria rapid diagnostic test procurement for endemic country national malaria control programs sustains the largest infectious disease POC unit volume globally.
By setting, the public health field programs segment is projected to register the highest growth rate through 2034, as international donor investment in decentralized infectious disease testing for global health programs is driving systematic POC test deployment in community and field settings.
9. Regional Analysis
Regional demand patterns across the Point of Care Infectious Disease Testing Market reflect differences in regulation, technological maturity, and capital investment.
Largest Market Share
North America dominated the Point of Care Infectious Disease Testing Market in 2025, accounting for around 34 percent of global revenue. The United States sexual health clinic and emergency department infectious disease POC testing combined with substantial HIV testing program funding drives the largest North American regional market. Abbott, Cepheid, and OraSure generate significant U.S. infectious disease POC revenue. Moreover, U.S. STI incidence growth is driving systematic POC STI testing program investment.
Highest CAGR Region
Africa is projected to register the highest CAGR in the Point of Care Infectious Disease Testing Market through 2034. The region's high HIV, malaria, and tuberculosis burden combined with substantial international donor funding for POC diagnostic access creates the most dynamic infectious disease POC market. PEPFAR, Global Fund, and WHO procurement programs drive systematic POC infectious disease test distribution. Moreover, Sub-Saharan African national health programs are building sustainable domestic infectious disease POC testing capacity.
10. Full Report with Exclusive Insights
The complete published market report includes an in-depth analysis of market dynamics, industry trends, competitive landscape, regional outlook, and future growth opportunities. The study provides detailed market sizing and forecasts across key segments and geographies, along with comprehensive insights into drivers, restraints, opportunities, challenges, technological advancements, regulatory landscape, and evolving consumer and industry trends. The report also features company profiles, strategic developments, market share analysis, and actionable recommendations to support informed business decision-making. Additionally, the syndicated report package typically includes forecast datasets, charts and figures, research methodology, and analyst support for strategic interpretation and planning.
Advanced Strategic & Custom Intelligence
In addition to the standard syndicated report package, TrendX Insights can provide the following advanced strategic analyses and customized intelligence solutions for any market:
Standard Report Coverage
- • Competitor Analysis
- • Country Trade Analysis
- • Import & Export Analysis
- • Porter’s Five Forces Analysis
- • SWOT Analysis by Companies
- • TrendX Insights Quadrant Positioning
- • Pricing Analysis
- • Detailed Macro-Economic Indicators Assessment
- • List of Raw Material Suppliers
- • Regulatory Framework Assessment
- • Supply Chain Resilience Mapping
- • Value Chain Analysis
- • Technology adoption trends and innovation tracking
- • Custom company profiling and benchmarking
Exclusive Sections With Additional Cost
- • Agentic AI Readiness Score
- • TAM, SAM, and SOM Analysis
- • AI Act & Privacy Compliance Audit
- • Channel Partner Ecosystem Mapping
- • China + 1 Strategy Analysis
- • Circular Economy Opportunities Assessment
- • Competitor Benchmarking KPI Analysis
- • Country Trade Analysis
- • Country-level opportunity mapping
- • Digital Maturity Matrix
- • Ecosystem Interdependency Mapping
- • ESG & Decarbonization Roadmap
- • Geopolitical Friction Scorecard
- • Geopolitical Risk Assessment
- • Humanoid Workforce Impact Analysis
- • Investment Heatmap
- • List of Distributors and Channel Partners
- • List of Raw Material Suppliers
- • Market Entry Strategy Assessment
- • Mergers & Acquisitions (M&A) Analysis
- • Patent & Intellectual Property (IP) Analysis
- • Pilot Project Analysis
- • Potential High-Growth Region/Country Investment Assessment
- • Product Comparison Analysis
- • Product Revenue Analysis
- • R&D Investment Analysis in Emerging Technologies
- • Raw Material Scarcity Forecast
Note: For highly customized requirements, deeper strategic assessments, company-specific intelligence, or tailored consulting support, please contact TrendX Insights.
Full Report with Exclusive Insights
Available to clients on request
Explore Our Published Reports Library
This page covers market-level data estimates. For comprehensive published research reports including full methodology, primary data, and detailed company profiles, browse the TrendX Insights Published Reports Library.
Visit Published Reports Library ›11. Related Market Reports
Frequently Asked Questions
The Point of Care Infectious Disease Testing Market was valued at USD 5.85 Bn in 2025 and is projected to reach USD 12.29 Bn by 2034, growing at a CAGR of 8.6% over the 2026–2034 forecast period.
The Point of Care Infectious Disease Testing Market is projected to grow at a CAGR of 8.6% from 2026 to 2034.
North America dominated the Point of Care Infectious Disease Testing Market in 2025, accounting for around 34 percent of global revenue.
The leading companies in the Point of Care Infectious Disease Testing Market include Abbott Laboratories, Roche Diagnostics, bioMerieux, Cepheid, SD Biosensor, Chembio Diagnostics, OraSure Technologies, Molbio Diagnostics, Tulip Diagnostics, Atomo Diagnostics.
Sti poc testing expansion is addressing a public health priority as chlamydia, gonorrhea, and syphilis incidence continues rising in developed and developing country settings.
By disease category, the malaria and dengue POC segment dominated the Point of Care Infectious Disease Testing Market in 2025, as high-volume public health malaria rapid diagnostic test procurement for endemic country national malaria control programs sustains the largest infectious disease POC unit volume globally.
How to Order
Purchasing a TrendX Insights report is straightforward. Our process is designed to be transparent and risk-free for buyers, with a 20% upfront model and full delivery before the balance payment.
This is the price of the syndicated report. Any custom inclusions beyond the Table of Contents will be scoped and priced separately. For the full list of what is covered in the syndicated report, refer to the Table of Contents tab.
A curated, condensed version of this report for students, researchers, and academic institutions. Ideal for thesis work, dissertations, and academic projects. Delivered as PDF to your institutional email.
Valid student ID or institutional email required. For educational and non-commercial use only.